Eli Lilly Pills - Search News

New weight loss pill to be approved by early 2026

Hosted on MSN · 21h

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

Business Insider · 2d

Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026

Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an

BayStreet · 1d

Eli Lilly Buys Cancer Therapy And Announces Timing Of Weight Loss Pill

Pharmaceutical giant Eli Lilly & Co. (LLY) is buying privately held Scorpion Therapeutics’ experimental cancer therapy for $2.5 billion U.S. in cash. Eli Lilly is purchasing Scorpion’s experimental oral therapy called “STX-478,

1d

Eli Lilly misses 2024 revenue numbers, but GLP-1 pill may help

Global pharmaceutical company Eli Lilly's (LLY) preliminary 2024 revenue missed expectations on lower-than-expected sales of ...

24/7 Wall St. on MSN22h

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

Pfizer Cautiously Optimistic on Obesity Pill as Kailera Challenges Lilly’s Zepbound With Strong Phase II Data

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

6don MSN

Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results